The administration is warning consumers and health care providers about treatments using plasma from young donors.
If you’re planning on getting infused with young blood to fight memory loss and aging, the US Food and Drug Administration would like you to reconsider.
FDA Commissioner Scott Gottlieb and Peter Marks, director of the Center for Biologics Evaluation and Research, warned in a statement Tuesday against getting infused with blood plasma from young donors. Claims that these infusions can help treat conditions such as dementia, Parkinson’s disease, Alzheimer’s disease, heart disease and post-traumatic stress disorder haven’t been clinically proven, the FDA said.
” We have significant public health concerns about the promotion and use of plasma for these purposes,” Gottlieb and Marks said. “There is no proven clinical benefit of infusion of plasma from young donors to cure, mitigate, treat, or prevent these conditions, and there are risks associated with the use of any plasma product.
